Gayle L. McCloskey, MD, FAAD
Dr. McCloskey is a Board-Certified Dermatologist. She had acne when she was younger, which lends her a unique perspective on her patients’ skin conditions. Having been a patient herself, she truly puts her heart and soul into the treatment she provides. She also takes great pride in the fact that she completed her dermatology residency at the world-renowned Mayo Clinic. Her advice to anyone who might be nervous about a procedure is that she will do her best to make them as comfortable as possible while answering any and all questions honestly and directly.
- Education
-
Medical Degree:
Loyola University-Stritch School of Medicine, ILInternal Medicine Internship:
Loyola University Medical Center/Hines VA Hospital, ILDermatology Residency:
Mayo Clinic Foundation, MN - Certificates
- Board-Certified Dermatologist (American Board of Dermatology)
- Professional Memberships
- American Academy of Dermatology
American Medical Association
Chicago Dermatological Society
Women's Dermatologic Society
O'Leary Society - Achievements
- Paul A. O'Leary Award for Clinical Excellence in Dermatology
Roy S. Rogers III Travel Award for Excellence in Patient Care
Alpha Omega Alpha, Vice President Epsilon Chapter of Illinois
Janet M. Glasgow Memorial Achievement Citation
CRC Press Chemistry Award
Summa cum laude
Highest Scholastic Achievement Award, Alpha Tau Delta
Kappa Gamma Pi Honor Society
Delta Epsilon Sigma Honor Society
Dean's List - Publications
van der Kooi, K, Davis, MPD, McCloskey, G. Chronic edema of the lips-a rare but real problem: A report of 3 cases and their response to therapy. JAAD 2005; 53(5): 875-877.
Randle, HW, McCloskey, GL. Diseases of the Mouth, in Conn’s Current Therapy 52nd Edition, Edited by RE Rakel, WB Saunders, Philadephia, 2000.
McCloskey, GL, Massa MC. Cephalexin rash in infectious mononucleosis: Case report and review of related literature. Cutis 1997; 59(5): 251-4.
Young, MRI, McCloskey, G Wright, MA, Pak, AS. Increasing infiltration and activation of DC8(+) tumor-infiltrating lymphocytes after eliminating immune suppressive granulocyte/macrophage progenitor cells with low doses of interferon and tumor necrosis factor. Cancer Immunology Immunotherapy. jan 1994. 38(1); 9-15.
*Age Restriction
For patients scheduling who are under 18 years of age (19 in Alabama) please make sure you have permission from your parent or legal guardian to schedule this appointment. Your parent or legal guardian must accompany you on your initial visit and on certain subsequent visits to provide appropriate informed consent.